newsfilter
← Latest News
Business Wire·

Graphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and Exposition

Graphite Bio, Inc. (NASDAQ:GRPH), a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with the potential to treat or cure serious